<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02074124</url>
  </required_header>
  <id_info>
    <org_study_id>H-3-2012-067</org_study_id>
    <secondary_id>H-3-2012-067</secondary_id>
    <nct_id>NCT02074124</nct_id>
  </id_info>
  <brief_title>CT Perfusion Changes in GI Cancer During Adenosine Vasodilation Test</brief_title>
  <official_title>Abdominal Tissue Perfusion Changes in Esophageal and Gastric Cancer During Adenosine Vasodilation Measured With Computed Tomography (CT) Perfusion</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Copenhagen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Copenhagen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study was to investigate changes in abdominal tissue perfusion during
      adenosine vasodilation. Our hypotheses were that CT perfusion measurements are altered by
      changes in the circulatory system mediated by adenosine, and a more differentiated assessment
      of the circulatory capacity of abdominal tumours could be achieved by sequential rest and
      adenosine vasodilation CT perfusion measurements.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2012</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">August 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change in arterial flow during adenosine vasodilation test (CT perfusion parameter)</measure>
    <time_frame>0 min and 15 min</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Blood pressure during adenosine vasodilation test</measure>
    <time_frame>0 min and 15 min</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Heart rate during adenosine vasodilation test</measure>
    <time_frame>0 min and 15 min</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Area under arterial input curve during adenosine vasodilation test</measure>
    <time_frame>0 min and 15 min</time_frame>
    <description>Area Under Curve (AUC) is correlated to cardiac output</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Blood volume (CT perfusion parameter) during adenosine vasodilation test</measure>
    <time_frame>0 min and 15 min</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Permeability (CT perfusion parameter) during adenosine vasodilation test.</measure>
    <time_frame>0 min and 15 min</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">15</enrollment>
  <condition>Esophageal Cancer</condition>
  <condition>Gastric Cancer</condition>
  <arm_group>
    <arm_group_label>Adenosine Vasodilation test</arm_group_label>
    <description>Group scanned with CT perfusion during adenosine vasodilation test.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Reference group</arm_group_label>
    <description>Group scanned twice without adenosine vasodilation test for a reference. No randomization.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with biopsy proven tumors in esophagus or stomach
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Tumour larger than 1.5 cm on diagnostic CT

          -  Normal serum creatinine

          -  Age above 18

          -  Informed written and oral consent.

        Exclusion Criteria:

          -  Contrast allergy or contrast induced nephropathy

          -  BMI &gt; 40

          -  Asthma or Chronic Obstructive Lung Disease

          -  Heart failure (NYHA III+)

          -  Heart conduction disorder

          -  Atrial fibrillation

          -  2nd/3rd Heart block

          -  Long QT syndrome

          -  Wolf Parkinson White Syndrome

          -  Moderate / severe aortic stenosis

          -  Haemodynamic contraindications for adenosine, systolic pressure below 90
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Martin L Hansen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rigshospitalet, Denmark</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Rigshospitalet</name>
      <address>
        <city>Copenhagen</city>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 20, 2014</study_first_submitted>
  <study_first_submitted_qc>February 26, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 28, 2014</study_first_posted>
  <last_update_submitted>February 26, 2014</last_update_submitted>
  <last_update_submitted_qc>February 26, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 28, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rigshospitalet, Denmark</investigator_affiliation>
    <investigator_full_name>Martin Lundsgaard Hansen</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stomach Neoplasms</mesh_term>
    <mesh_term>Esophageal Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adenosine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

